The global human embryonic stem cells market size is expected to reach USD 4.08 billion by 2030, registering to grow at a CAGR of 10.5% from 2024 to 2030 . Application of hESCs as a promising donor source for cellular transplantation therapies is anticipated to bolster progress through to 2025. hESCs technology tends to be useful for tissue engineering in humans due to high histocompatibility between host and graft.
Maintenance of developmental potential for contribution of derivatives of all three germ layers is an important feature of these cells. This ability remains consistent even after clonal derivation or prolonged undifferentiated proliferation, thus pronouncing its accelerated uptake.
In addition, these are capable in expressing high level of alkaline phosphatase, key transcription factors, and telomerase. These factors are found to be of great importance in the maintenance of the inner cellular mass pluripotency.
Furthermore, hESCs can be easily differentiated into defined neurons, neural lineages, oligodendrocytes, and astrocytes. Aforementioned characteristic makes it useful in studying the sequence of events that take place during early neurodevelopment.
However, use of stem cells derived from viable embryos is fraught with ethical issues, prompting scientists to explore other methods to generate ESCs. The other methods include derivation of embryonic germ cells, stem cells from dead embryos, and other techniques.
This product will be delivered within 1-3 business days.
Maintenance of developmental potential for contribution of derivatives of all three germ layers is an important feature of these cells. This ability remains consistent even after clonal derivation or prolonged undifferentiated proliferation, thus pronouncing its accelerated uptake.
In addition, these are capable in expressing high level of alkaline phosphatase, key transcription factors, and telomerase. These factors are found to be of great importance in the maintenance of the inner cellular mass pluripotency.
Furthermore, hESCs can be easily differentiated into defined neurons, neural lineages, oligodendrocytes, and astrocytes. Aforementioned characteristic makes it useful in studying the sequence of events that take place during early neurodevelopment.
However, use of stem cells derived from viable embryos is fraught with ethical issues, prompting scientists to explore other methods to generate ESCs. The other methods include derivation of embryonic germ cells, stem cells from dead embryos, and other techniques.
Human Embryonic Stem Cells Market Report Highlights
- Regenerative medicines dominated the market with a share of 61.1% in 2023. Regenerative medicines offer significant advancements in treating several diseases. Moreover, pluripotent cells originating from human embryos have been central to biomedical research.
- The stem cell biology research segment is expected to witness the fastest CAGR of 11.4% over the forecast period. Several biopharmaceutical companies have explored the potency of stem cell biology in the past.
- North America human embryonic stem cells dominated the market in 2023 owing to robust research infrastructure institutions and facilities. The rise in chronic diseases and genetic disorders has created a huge demand for gene therapies.
- Asia Pacific human embryonic stem cell market is anticipated to witness significant growth in the forecast period.
The leading players in the Human Embryonic Stem Cells market include:
- Thermo Fisher Scientific, Inc.
- PromoCell GmbH
- Lonza
- STEMCELL Technologies
- Merck KGaA
- CellGenix GmbH
- Takara Bio
- Cellartis AB
- ATCC
- AcceGen
- Cell Applications, Inc.
- Bio-Techne
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Human Embryonic Stem Cells Market Variables, Trends, & Scope
Chapter 4. Human Embryonic Stem Cells Market: Application Estimates & Trend Analysis
Chapter 5. Human Embryonic Stem Cells Market: Regional Estimates & Trend Analysis
Chapter 6. Competitive Landscape
Companies Mentioned
The leading players in the Human Embryonic Stem Cells market include:- Thermo Fisher Scientific, Inc.
- PromoCell GmbH
- Lonza
- STEMCELL Technologies
- Merck KGaA
- CellGenix GmbH
- Takara Bio
- Cellartis AB
- ATCC
- AcceGen
- Cell Applications, Inc.
- Bio-Techne
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 100 |
| Published | September 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 2.02 Billion |
| Forecasted Market Value ( USD | $ 4.08 Billion |
| Compound Annual Growth Rate | 10.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 13 |
